On Thursday, Valeo Health, a UAE-based health tech innovator, announced that it has successfully raised $12 million in a Series B funding round. The company’s $20 million fundraising strengthens its GCC leadership in AI-driven healthcare solutions.
Read also: Tanzanian startup Sumet Technologies raises $1.5 million to optimise FMCG distribution across Africa
Funding and investor support
Flintera led the funding round, which included existing investors Nuwa Capital, FJ Labs, Oryx, and Mindshift Capital, as well as new investors Oraseya and Eirad. This strong investor support underscores the growing confidence in Valeo Health’s innovative approach to personalised healthcare.
Sundeep Sahni, CEO and co-founder of Valeo Health, expressed enthusiasm for the investment, stating, “We are thrilled by the strong investor support as we continue to redefine how people engage with their health. This funding enables us to scale our AI technology, enhance our product offerings, and expand our reach, ensuring more individuals benefit from proactive healthcare solutions.”
Nitin Reen, Partner at Nuwa Capital, highlighted the potential for deeper customer engagement, noting, “With this round, we have the opportunity to deepen the customer centricity and provide even more value to our most important stakeholder”.
Read also: Commercial Bank of Ethiopia launches virtual and plastic cards with MasterCard
Valeo Health expands personalised care in GCC
Valeo Health plans to utilise the funds to accelerate its mission to make personalised, science-backed healthcare solutions more accessible across Saudi Arabia, the UAE, and the broader GCC region.
The company will focus on scaling its AI technology, enhancing product offerings, and expanding its reach in key markets. This expansion will enhance predictive analytics and workflow automation capabilities, allowing medical professionals to provide more efficient and data-driven care.
Valeo Health’s proprietary Longevity technology enables at-home healthcare services, proactive treatment plans, and real-time health monitoring, setting a new standard for digital health solutions across the GCC. The company’s commitment to empowering individuals with real-time insights and tailored health and wellness solutions positions it as a pioneering leader in AI-driven healthcare.